{"database": "lobbying", "table": "lobbying_activities", "rows": [[1453543, "035f33ba-55f6-4c15-bf03-4aa8b2de44c1", "Q3", "BROWN RUDNICK LLP", 287895, "APOTEX CORPORATION", 2013, "third_quarter", "PHA", "H.R. 3204: The Drug Quality and Safety Act\nS. 959: The Pharmaceutical Quality, Security and Accountability Act", "HOUSE OF REPRESENTATIVES,SENATE", 40000, null, 0, 0, "2013-10-18T15:35:48.717000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1453543"], "units": {}, "query_ms": 29.99100397573784, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}